Checchi Capital Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$842K Buy
8,141
+5
+0.1% +$446 0.04% 255
2026
Q1
$584K Buy
8,136
+1,433
+21% +$110K 0.03% 322
2025
Q4
$532K Buy
6,703
+275
+4% +$21.7K 0.03% 308
2025
Q3
$485K Buy
6,428
+54
+0.8% +$3.7K 0.03% 332
2025
Q2
$440K Sell
6,374
-843
-12% -$55.3K 0.02% 363
2025
Q1
$489K Buy
7,217
+1,296
+22% +$77.6K 0.03% 341
2024
Q4
$266K Sell
5,921
-2,365
-29% -$133K 0.02% 467
2024
Q3
$521K Buy
8,286
+1,476
+22% +$86.1K 0.03% 320
2024
Q2
$402K Sell
6,810
-4,096
-38% -$256K 0.02% 371
2024
Q1
$870K Sell
10,906
-136
-1% -$10.4K 0.07% 215
2023
Q4
$872K Buy
11,042
+637
+6% +$45.3K 0.07% 202
2023
Q3
$726K Buy
10,405
+233
+2% +$16.5K 0.07% 215
2023
Q2
$703K Sell
10,172
-1,598
-14% -$114K 0.06% 226
2023
Q1
$875K Sell
11,770
-402
-3% -$33.7K 0.08% 186
2022
Q4
$1.13M Sell
12,172
-620
-5% -$59.8K 0.12% 146
2022
Q3
$1.22M Buy
12,792
+48
+0.4% +$4.75K 0.11% 134
2022
Q2
$1.22M Sell
12,744
-403
-3% -$39.3K 0.11% 141
2022
Q1
$1.33M Buy
13,147
+2,229
+20% +$234K 0.11% 130
2021
Q4
$1.13M Buy
10,918
+815
+8% +$75.3K 0.1% 141
2021
Q3
$857K Buy
10,103
+183
+2% +$15.3K 0.08% 157
2021
Q2
$828K Buy
9,920
+264
+3% +$21.6K 0.08% 170
2021
Q1
$726K Buy
9,656
+177
+2% +$12.9K 0.07% 179
2020
Q4
$647K Sell
9,479
-171
-2% -$11.1K 0.07% 193
2020
Q3
$564K Sell
9,650
-1,568
-14% -$97.6K 0.06% 191
2020
Q2
$729K Buy
11,218
+1,851
+20% +$117K 0.09% 146
2020
Q1
$556K Buy
9,367
+1,543
+20% +$103K 0.05% 156
2019
Q4
$581K Sell
7,824
-469
-6% -$32.9K 0.08% 183
2019
Q3
$523K Sell
8,293
-249
-3% -$14.8K 0.07% 185
2019
Q2
$465K Sell
8,542
-1,224
-13% -$65.9K 0.06% 206
2019
Q1
$527K Sell
9,766
-523
-5% -$32.3K 0.06% 177
2018
Q4
$674K Buy
10,289
+912
+10% +$68.1K 0.09% 138
2018
Q3
$738K Buy
9,377
+1,266
+16% +$90.5K 0.09% 152
2018
Q2
$522K Buy
8,111
+143
+2% +$9.42K 0.07% 189
2018
Q1
$496K Sell
7,968
-1,095
-12% -$78.6K 0.07% 191
2017
Q4
$657K Buy
9,063
+1,150
+15% +$83.6K 0.09% 158
2017
Q3
$643K Sell
7,913
-1,024
-11% -$81K 0.07% 138
2017
Q2
$719K Sell
8,937
-709
-7% -$56K 0.08% 125
2017
Q1
$757K Buy
9,646
+730
+8% +$58.3K 0.09% 125
2016
Q4
$704K Sell
8,916
-863
-9% -$69.8K 0.09% 124
2016
Q3
$870K Sell
9,779
-193
-2% -$18.2K 0.1% 97
2016
Q2
$955K Buy
9,972
+307
+3% +$30.6K 0.11% 83
2016
Q1
$1M Sell
9,665
-1,036
-10% -$101K 0.22% 83
2015
Q4
$1.05M Buy
10,701
+882
+9% +$86.4K 0.26% 82
2015
Q3
$947K Buy
9,819
+682
+7% +$71.7K 0.26% 75
2015
Q2
$958K Sell
9,137
-1,075
-11% -$110K 0.25% 75
2015
Q1
$1.05M Buy
10,212
+1,330
+15% +$135K 0.31% 67
2014
Q4
$855K Buy
8,882
+789
+10% +$69.5K 0.32% 70
2014
Q3
$644K Buy
8,093
+2,859
+55% +$225K 0.26% 82
2014
Q2
$394K Buy
5,234
+1,092
+26% +$82.5K 0.18% 105
2014
Q1
$310K Buy
4,142
+868
+27% +$61.3K 0.19% 108
2013
Q4
$234K Buy
+3,274
New +$210K 0.18% 116

Other funds holding CVS

Checchi Capital Advisers's CVS Position: Q2 2026 in Review

Checchi Capital Advisers increased its CVS Health (CVS) stake by 0.06% in Q2 2026, buying an estimated $446 and bringing the position to 8,141 shares worth $842K. The position accounts for 0.04% of the portfolio, ranked #255.

Checchi Capital Advisers first reported a position in CVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.33M in Q1 2022. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Checchi Capital Advisers held 8,141 shares of CVS Health worth $842K as of Q2 2026.
  • Checchi Capital Advisers bought 5 CVS Health shares in Q2 2026, an estimated $446.
  • CVS Health made up 0.04% of Checchi Capital Advisers's portfolio in Q2 2026, its #255 holding.
  • Checchi Capital Advisers first reported a position in CVS Health in Q4 2013 and has held it in 51 quarters since.
  • Checchi Capital Advisers's CVS Health position peaked at $1.33M in Q1 2022.
  • 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.